Monthly Archives: October 2013

JOBS Act Deconstructed: Confidential Filing

AB23475

More than 40 biotech companies have gone public using provisions made available to emerging growth companies through the JOBS Act. BIOtechNOW’s JOBS Act Deconstructed series will explore why it has had such an impact on biotech offerings and how emerging companies can leverage the new law to their best advantage. Any company conducting a public offering must file a registration statement, called an S-1, with the SEC.  The purpose of this document is to inform investors Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Washington Gov. Jay Inslee to Keynote BIO Convention in China

Gov_Inslee_115x76

Next month, BIO will be hosting our 3rd Annual BIO Convention in China, November 11-13. We are very pleased that Washington Governor Jay Inslee will be joining us as our keynote speaker on November 12. “China is a rapidly growing market for America’s innovative biotechnology companies, including those in Washington State. As this market continues to expand, it will be increasingly important to develop collaborative relationships with the Chinese government, companies, and academic institutions. The BIO Convention Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Synthetic Biology Applications for Algae and Renewable Chemicals Featured at 2013 Pac Rim Summit

Pac_Rim115x75

The Biotechnology Industry Organization’s (BIO)’s 2013 Pacific Rim Summit on Biotechnology and Bioenergy will be showcasing several distinctive presentations on recent innovations in using synthetic biology for renewable chemicals and algae biofuels.  This year’s summit will be co-organized by BIOCOM and held in San Diego, California from December 8-11, 2013 at the Westin Gaslamp Quarter. In a recent press release, BIO announced that the Pacific Rim Summit will offer a complete track of breakout sessions on the Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

JOBS Act Deconstructed: Testing-the-Waters

87881842

More than 40 biotech companies have gone public using provisions made available to emerging growth companies through the JOBS Act. BIOtechNOW’s JOBS Act Deconstructed series will explore why it has had such an impact on biotech offerings and how emerging companies can leverage the new law to their best advantage. The JOBS Act enables companies to promote themselves to potential investors in advance of their IPO. Prior to the JOBS Act, companies conducting a public offering Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

GAIN Act: A Great First Step

clinical-trials

With over 2 million infections – and 23,000 deaths – caused by antibiotic resistant bacteria each year in the US, everyone agrees there is an urgent need to find new, effective antibiotic therapies. One measure designed to spur such development is the Generating Antibiotics Incentives Now (GAIN) Act, signed into law last year. Given the growing threat posed by resistant bacteria, we decided to hold a workshop with leading experts about what effect the GAIN Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , ,